Gelatin prototypes for medical devices at COMPAMED 2025

Rousselot, the leading collagen and gelatin brand from Darling Ingredients, will be present at COMPAMED 2025, 17–20 November, in Düsseldorf, Hall 8, Booth AK14, highlighting the benefits of gelatin as a versatile biomaterial for medical devices. Visitors can engage directly with Rousselot experts and explore application-focused prototypes – including hemostats, dermal fillers, and microneedles – developed to accelerate formulation and reduce time to market.

Featured demonstrations will include gelatin-based films and foams for hemostatic sponges or anti-adhesion applications, flowable hemostats with adjustable viscosity, bioresorption, and hemostatic efficiency, dermal fillers offering tailored rheology, injectability, and biocompatibility, and microneedle prototypes showing optimised mechanical strength, dissolution, and active ingredient delivery.

Gelatin is widely recognised for its physicochemical properties and biocompatibility, and Rousselot’s portfolio of modified and non-modified gelatins is known for high purity, consistent quality, and comprehensive regulatory documentation, helping developers reduce variability and support faster market entry. Attendees are invited to arrange meetings with Rousselot’s technical and regulatory teams to discuss standard and customised solutions for medical device development. 

More information online